Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Return on Invested Capital (2020 - 2024)

Celularity (CELU) has disclosed Return on Invested Capital for 5 consecutive years, with 0.7% as the latest value for Q3 2024.

  • On a quarterly basis, Return on Invested Capital rose 139.0% to 0.7% in Q3 2024 year-over-year; TTM through Sep 2024 was 0.7%, a 139.0% increase, with the full-year FY2023 number at 1.3%, down 114.0% from a year prior.
  • Return on Invested Capital was 0.7% for Q3 2024 at Celularity, up from 3.51% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.89% in Q3 2021 to a low of 3.68% in Q4 2023.
  • A 5-year average of 0.93% and a median of 0.49% in 2022 define the central range for Return on Invested Capital.
  • Peak YoY movement for Return on Invested Capital: tumbled -356bps in 2023, then surged 139bps in 2024.
  • Celularity's Return on Invested Capital stood at 0.28% in 2020, then tumbled by -492bps to 1.12% in 2021, then surged by 90bps to 0.12% in 2022, then plummeted by -3064bps to 3.68% in 2023, then skyrocketed by 81bps to 0.7% in 2024.
  • Per Business Quant, the three most recent readings for CELU's Return on Invested Capital are 0.7% (Q3 2024), 3.51% (Q2 2024), and 2.97% (Q1 2024).